Sponsored by
Organized by
医薬品の研究・開発・製造をサポートするためのオンラインプログラム
ー 2年間で延べ3万人を超える製薬関係者が視聴 ―
CPHI Japan ウェビナー
[ Free ] Video for Archive (New)
CPHI Japan Webinars
【Part 2 - 3 】
Presentation by leading Japanese API manufacturers
Development of Ru-Catalysts (DENEB®, RUCY®, Ru-MACHO®) and Its Application
Takasago International Corporation
Open Period：June 08, 2022 - July 29, 2022
Language
CPHI Japan Webinars
【Part 3 】
Regarding the revision of the Pharmaceutical Machinery Law and the GMP Ministerial Ordinance and the efforts of the Kyoto Prefectural Pharmaceutical Affairs Support Center
Kyoto Prefectural Health and Welfare Department Pharmaceutical Affairs Division (Kyoto Prefectural Pharmaceutical Affairs Support Center)
Chief examiner
Mr. Ryoichi Tanaka
Open Period：June 08, 2022 - July 29, 2022
Language
CPHI Japan Webinars
【Part 2 - 1 】
Presentation by leading Japanese API manufacturers
Breakthrough Peptide Manufacturing by Molecular HivingTM
SPERA NEXUS, Inc./ Jitsubo CO., LTD.
Open Period：June 08, 2022 - July 29, 2022
Language
CPHI Japan Webinars
【Part 2 - 2 】
Presentation by leading Japanese API manufacturers
Challenges and Opportunities for small molecule CDMO
Juzen Chemical Corporation
Open Period：June 08, 2022 - July 29, 2022
Language
Global R & D Trends in Pharmaceuticals 2022 ~ Changes and Impact of Covid-19 ~
<Speaker> Informa plc Pharma Intelligence
Language
Environmental Sustainability in Pharmaceutical Companies:
Consideration of Pharmaceutical Companies' Steps toward Positive Impact
<Speaker> IQVIA Japan Group
Language
Impact of COVID-19 on clinical trials
<Speaker> Informa Pharma Intelligence
Language
Dove Medical Press Publishing
Open Access and Asian Academic Publishing Trends
＜Speaker＞ Taylor ＆Francis
Language
[ Free ] Video for Archive* No Period
Regulation / Market
Pharma R&D Annual Review 2020（2020年の世界医薬品市場のトレンド）
＜Speaker＞ Ian LloydSenior Director, Pharmaprojects & Data Integration, Informa
Language
FDA and its Commissioners -世界の薬事規制と承認審査に関するニュース-
＜Speaker＞ Nielsen Hobbs, Executive Editor, Pink SheetNancy Mayers,
President and Founder, Catalyst Healthcare Consulting Inc.
Language
Manufacturing / Quality Control
Empty
Bio Pharma
Manufacturing Challenges Facing Cell and Gene Therapy
＜Speaker＞ Amanda Micklus, Principal Analyst, Informa
Language
R&D
2020 Early Outlook Webinar -2020年前半の市場動向レポートと考察 -
＜Speaker＞ Michael Haydock, Senior Director, Infectious Disease,
Cardiovascular and Metabolic Dominique Fontanilla, PhD.
Therapeutic Area Director, CNS and Immunology and Inflammation
Informa
Language